Representantes internacionales

Committee DDC on Preeclampsia (C67-Ed1) (Contributor)

Committee on Lead Testing in Blood and Urine (C40) (Voting member)

Committee DDC on Data Collection Methods (AUTO18-Ed1) (Contributor)

Document Development Committee (DDC) on Newborn Screening for Spinal Muscular Atrophy (NBS13) (Member)

Grupo de Trabajo de Autoinmunidad (Miembro)

El Grupo de Trabajo de Autoinmunidad de COLABIOCLI (GTAC) se conformó el 17 de julio de 2024 con el objetivo general de fortalecer a COLABIOCLI en el área del diagnóstico de enfermedades autoinmunes, contribuyendo a la difusión facilitada de los profesionales de Laboratorio Clínico en relación a la aplicación de pruebas de autoanticuerpos en patologías autoinmunes de diferentes áreas médicas.

Technical Committee “Awards and Grants” (TC-AG) (Full member)

Terms of reference:

  • To directly evaluate nominations for the EFLM Awards recognising a distinguished individual who has made an important contribution to the field of Laboratory Medicine;
  • To identify subject-matter experts, where direct evaluation is not undertaken, to judge applications for the EFLM Awards recognising an outstanding paper in specific areas of Laboratory Medicine;
  • To directly evaluate, or to evaluate through co-opted experts if necessary, the applications for the EFLM Research Grant;
  • To identify new opportunities for EFLM awards and grants to be launched, including potential sponsorship arrangements.

Committee Young Scientists (Member)

Terms of Reference

  • Raising awareness of young scientists in laboratory medicine
  • Building a communication network of young scientists and laboratory professionals in Europe
  • Facilitate professional and scientific exchange of young scientists, e.g., through EFLMLabX exchange program
  • Regularly reporting about the activities of mother EFLM functional units and home countries in EFLM communication channels (Newsletter, social media, website)

Committee Young Scientists (Member)

Terms of Reference

  • Raising awareness of young scientists in laboratory medicine
  • Building a communication network of young scientists and laboratory professionals in Europe
  • Facilitate professional and scientific exchange of young scientists, e.g., through EFLMLabX exchange program
  • Regularly reporting about the activities of mother EFLM functional units and home countries in EFLM communication channels (Newsletter, social media, website)

Endocrine Laboratory Medicine C-ENDO (Corresponding Members)

Terms of Reference

  • To facilitate collaboration and knowledge exchange among European specialists in endocrine laboratory medicine.
  • To provide expert input for guideline development, standardization, and educational initiatives in partnership with the European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE).
  • To address key challenges such as pre-analytical optimization, reference intervals, and harmonization of hormone assays.
  • To initiate and support research, publications, and European projects to advance the field of endocrine laboratory medicine.

Science Committee: Working Group on Biological Variation (WG-BV) (Full member); Task Group: “Biological variation database” (TG-BVD)(Member)

Terms of reference:

  • To develop the EFLM Biological Variation Database in collaboration with the Task Group on the Biological Variation Database
  • To publish biological variation data
  • To explore new methods to deliver biological variation estimates
  • To expand and maintain a database on biological variation data on the EFLM website
  • To cooperate with the TG-PSOS to allocate measurands to the different models in the Milan hierarchy
  • To develop APS for EQA organisations in cooperation with TG-PSOS

Committee: Direct-to-Consumer Laboratory Testing and Patient Empowerment

Terms of Reference

  • Education of laboratory specialists, law makers, and notified bodies how patients’ safety is guaranteed in IVD testing
  • Aid IVD vendors, testing services, and patients/consumers with the “intended use” of certain IVD testing services
  • Developing standards to be met when DTCT data has to be used for healthcare
  • Recommendations for or against the use of certain IVD tests as DTCT
  • Explore and promote the engagement of patients and professionals in enabling patients to receive individualised support in understanding what their results mean for them
  • Develop surveys and projects that support the above

Young Scientist Full Member of the EFLM Working Group “Vascular Risk Biomarkers” (WG-VRB)

 Terms of Reference:

  • To prepare an overview of lipoproteins and atherosclerosis risk marker assays available in Europe, their assay principles, and recommended result reporting
  • To obtain a comprehensive survey of laboratory practices in European countries to determine lipoproteins and risk marker concentrations and report results including the availability of molecular analysis
  • To compare EQA-schemes for lipoproteins and risk markers  among European countries
  • To provide recommendations on how to measure and report lipoproteins and risk markers
  • To follow-up evidence of emerging cardiovascular risk factors such as Lp(a), remnant lipoproteins and apolipoproteins, and prepare an update guidance for their measurements

Task Force: Green and Sustainable Laboratories (TF-GSL) (National EFLM TF-GSL Expert)

Terms of reference:

  • Informing and consulting EFLM member societies for implementing sustainable practices in medical laboratories
  • Establishing Guidelines (Green & Sustainable Lab Guide), Criteria and Key Recommendations for sustainable practices in clinical laboratories
  • Guiding the transition to Green Labs
  • Launching calls to receive applications for GREEN & SUSTAINABLE LAB Certification program
  • Evaluation of the applications and providing bi-annual certificates
  • Evaluation of GREEN & SUSTAINABLE LAB Certification applications for renewals.

Division’s Executive Committee Member
Executive Committee Member

Science Committee: Working Group on Biological Variation (WG-BV) (Full member); Task Group: “Biological variation database” (TG-BVD)(Member)

Terms of reference:

  • To develop the EFLM Biological Variation Database in collaboration with the Task Group on the Biological Variation Database
  • To publish biological variation data
  • To explore new methods to deliver biological variation estimates
  • To expand and maintain a database on biological variation data on the EFLM website
  • To cooperate with the TG-PSOS to allocate measurands to the different models in the Milan hierarchy
  • To develop APS for EQA organisations in cooperation with TG-PSOS

Task Force: Preparation of Labs for Emergencies (TF-PLE) (National society representative)

Terms of reference:

  • Survey EFLM Countries to understand the state-of-the-art on lab preparation for emergencies across Europe and possibly identify (or set) the benchmark
  • Define priority areas (i.e., type of emergencies) to become specific targets of laboratory medicine of the emergencies
  • Provide indications on suitable strategies to prepare laboratory medicine facilities to face emergencies

Commitee: European Regulatory Affairs (TF-ERA) (National society representative)

Terms of Reference

  • Drastically de-bureaucratize the IVDR in the upcoming revision process. 
    – To accomplish differential management for class C and B IVDs, since only the former are of high individual risk to patients and/or public health, while the latter represent half of all IVDs. Reduction of regulatory complexity for class B would allow concentration of resources for class C and D.
    – To reduce the certification requirements of class C and D in order to facilitate harmonization and optimization of management by the increasing number of Notified Bodies involved.
  • Accomplish recognition by regulators of established Laboratory Quality Assurance Systems such as External Quality Assessment schemes that should be integrated  into the IVDR framework
  • Organize strong EFLM support to ensure in-house tests can continue their vital role in the health system. A fundamental legal change of the IVDR should be strived for with regard to IH-IVDs as art 5.5 is not compatible with art 1 of the IVDR nor with art 168 of the EU Treaty (as healthcare systems are the responsibility of the Member States).
  • Advocate for a special regulatory pathway to facilitate the conformity assessment of rare/niche/orphan IVDs and to reduce the costs for their certification, while also ensuring against inappropriate use of this pathway.
  • Make post-market surveillance the path to identify “bad” IVDs, and IVDs with “short-comings” necessitating LDTs, while remedying the shortcomings should make those specific LDTs obsolete.
  • Develop an endorsed Regulatory Science module for educating European lab professionals and young scientists on the basics of IVDR and on its effects on the diagnostic ecosystem.

Technical Committee: Register (Full Member)

Terms of Reference

  • To adjudicate applications to hold the title European Specialist in Laboratory Medicine (EUSpLM);
  • To grow the EFLM Academy and the EuSpLM Register;
  • To support the Profession Committee in its strategy to achieve recognition of Specialists in Laboratory Medicine.

Science Committee; Working Group on Biological Variation; Task Group: “Biological variation database” (TG-BVD) (Member)

Terms of Reference:

  • To expand and maintain a database on biological variation data on the EFLM website
  • To cooperate with the TG-PSOS to allocate measurands to the different models in the Milan hierarchy
  • To develop APS for EQA organisations in cooperation with TG-PSOS

EFLM National Representative (Full member)

Science Committee: Working Group on Preanalytical Phase (WG-PRE) (Expert/consultant)

Terms of reference:

  • To promote the importance of the quality of the preanalytical phase of laboratory medicine
  • To define the best practices and provide recommendations for some critical activities in the preanalytical phase
  • To design and validate questionnaires for assessing the current practices related to some pre-analytical variables
  • To conduct surveys using validated questionnaires with the aim to assess the current pre-analytical practices
  • Organize symposia, workshops, webinars or training courses on preanalytical phase issues

Science Committee; Working Group on Artificial Intelligence (GW-AI) (Corresponding member)

Terms of Reference:

  • To establish the guideline for the use of laboratory data in Machine Learning
  • To evaluate the suitable application of the Machine Learning approach in Laboratory Medicine
  • To publish studies where Machine Learning algorithms are applied to well characterized laboratory data collected from different European laboratories for meaningful and appropriate tasks
  • To define interdisciplinary lectures and courses on Artificial Intelligence topics

Committee: Chronic Kidney Disease (Corresponding member)

Terms of Reference:

  • Promote GFR Measurement and Standardization in Europe.
  • Enhance the Promotion and Validation of the EKFC Equation.
  • Standardize and Promote the Use of Bone Turnover Markers in CKD.
  • Foster Cross-Disciplinary Collaboration Between Nephrology and Clinical
    Chemistry.
  • Survey and Harmonize Renal Function Testing in Europe
  • Support the Implementation of KDIGO Guidelines in Europe 

Science Committee: Working Group on Biological Variation (WG-BV) (Member Young Scientist)

Terms of Reference:

  • Raising awareness of young scientists in laboratory medicine
  • Building a communication network of young scientists and laboratory professionals in Europe
  • Facilitate professional and scientific exchange of young scientists, e.g., through EFLMLabX exchange program
  • Regularly reporting about the activities of mother EFLM functional units and home countries in EFLM communication channels (Newsletter, social media, website)

Committee Young Scientists (Member)

Terms of Reference

  • Raising awareness of young scientists in laboratory medicine
  • Building a communication network of young scientists and laboratory professionals in Europe
  • Facilitate professional and scientific exchange of young scientists, e.g., through EFLMLabX exchange program
  • Regularly reporting about the activities of mother EFLM functional units and home countries in EFLM communication channels (Newsletter, social media, website)

Committee: EFLM-CPECS

Terms or Reference:

  • Establishment and oversight of the EFLM-CPECS® System
    – Develop, implement, and maintain the CPECS® as the standardized credit system for certifying the quality of professional development events within EFLM’s scope.
    – Ensure that CPECS® credit assignments reflect rigorous standards for continuing education and continuous professional development (CE/CPD).
  • Evaluation and assignment of credit points
    – Review and assess applications from event providers to award CPECS® credits, adhering strictly to the established criteria.
    – Ensure consistency, transparency, and fairness in the assignment of credit points for CE/CPD events.
  • Guidance for CPECS® certification process
    – Provide comprehensive instructions and guidelines for event providers on the issuance of CPECS® certificates.
    – Support providers throughout the application and certification processes to uphold a high standard.
  • Collaboration with Accreditation Authorities
    – Work closely with National Accrediting Authorities and International Accreditation Bodies to facilitate mutual recognition of CPECS® credits with other CE/CPD credit systems.
    – Foster partnerships to enhance the credibility and acceptance of CPECS® credits across different regions and professional networks.

Committee Young Scientists (Member)

Terms of Reference

  • Raising awareness of young scientists in laboratory medicine
  • Building a communication network of young scientists and laboratory professionals in Europe
  • Facilitate professional and scientific exchange of young scientists, e.g., through EFLMLabX exchange program
  • Regularly reporting about the activities of mother EFLM functional units and home countries in EFLM communication channels (Newsletter, social media, website)

Technical Committee: Biological Variation Database (Member)

Terms of Reference

  • To improve the quality of BV data
  • To critically appraise published BV data
  • To expand and maintain a database on BV data on the BVD website
  • To explore how to evaluate data mining studies reporting BV data and how to incorporate these results in the BVD
  • To explore publishing an overview of which measurands are allocated to the different models in the Milan hierarchy in the BVD website

Committee Young Scientists (Member)

Terms of Reference

  • Raising awareness of young scientists in laboratory medicine
  • Building a communication network of young scientists and laboratory professionals in Europe
  • Facilitate professional and scientific exchange of young scientists, e.g., through EFLMLabX exchange program
  • Regularly reporting about the activities of mother EFLM functional units and home countries in EFLM communication channels (Newsletter, social media, website)

FESTEM Advisory board

Aims of the Federation
The FESTEM (Federation of European Societies on Trace Elements and Minerals) aims to encourage all kinds of activities in the field of trace elements and minerals including development of research or educational projects, organisation of scientific meetings, search for financial support through private or international organisations, etc.

Detailed information concerning the past and current activities of the FESTEM can be found in the Journal of Trace Elements in Medicine and Biology, the official organ of the Federation.

IFCC – Scientific Division: Working Group on Fecal Immunochemical Testing (WG – FIT) (Member)

Terms of Reference

  • To harmonise and/or standardise analysis of haemoglobin in faecal samples by immunochemistry (FIT)
  • To standardise the pre-analytical phase
  • To establish EQA and 3rd party IQC programmes
  • To determine impact of assay interference of Hb variants and other factors
  • To determine the feasibility of developing reference materials and/or commutable calibrators

IFCC – Education and Management Division – Committee on Value Proposition for Laboratory Medicine (C-VPLM) (Corresponding member)

Terms of Reference

  • To advocate adoption of the value proposition in laboratory medicine/healthcare
  • To develop a compendium of tools for laboratory medicine specialists to establish the value for individual medical tests within individual health care systems

IFCC-Committee on Emerging Technologies in Pediatric Laboratory Medine (C-ETPLM) (Corresponding member)

Terms of Reference

  • To identify, prioritise and coordinate projects to support the emerging science in pediatric laboratory medicine across the total testing process
  • To review the current concepts in Pediatric Laboratory Medicine and advance laboratory practice through the development and dissemination of position papers and guidelines
  • To develop existing links and establish new links with clinical and scientific societies working in other specialist organizations including neonatology, pediatrics, inherited metabolic diseases and other rare diseases
  • To lead education activities, including the tri-annual congress of Pediatric Laboratory Medicine
  • To coordinate a worldwide network of scientists working in laboratories specialized in Emerging Pediatric Laboratory Medicine (C-EPLM)
  • To work to support emerging economies in Pediatric Laboratory Medicine

IFCC-Congresses and Conferences Committee (C-CC) (Member)

Mission
The mission of the C-CC is to provide general administration and management of all IFCC meeting activities (congresses, conferences, and symposia) and to review  applications for IFCC auspices from non-IFCC conferences requesting such sponsorship.

IFCC-Communications and Publications Division: Working Group Ibero-American Nomenclature and Translations (WG-IANT) (Member)

Terms of Reference:

  • Organise and manage the Ibero-American corner on the web site
  • Editorial Board of the e-journal «Diagnostico in vitro» (edited by the chair of the WG-IANT)
  • Produce Spanish and Portuguese terminological documents
  • Produce Spanish and Portuguese translations of IFCC documents
  • Produce Spanish and Portuguese informative and educational documents

IFCC- Education and Management Division: Committee on Clinical Molecular Biology Curriculum (C-CMBC) (Member)

Terms of Reference:
The objective of the C-CMBC is to develop curriculum and hold training courses in Molecular Biology techniques. In addition, C-CMBC will develop techniques for teaching Clinical Molecular Biology in Laboratory Medicine and courses in teaching Clinical Molecular Biology.

Projects

  • Clinical Molecular Biology Courses
  • Symposia at International Congresses
  • Liaison with other special International Groups
  • Molecular Biology Courses at Regional Meetings

IFCC- Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) (Member)

  • Mission
    To develop and disseminate educational documents, materials and scientific presentations targeted towards clinical and analytical applications of cardiac biomarkers including, but not limited to, cardiac troponin (high-sensitivity, contemporary and point-of-care assays), natriuretic peptides (BNP, NT-proBNP assays) and emerging novel biomarkers.

IFCC – Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) (Corresponding Member)

  • Mission
    To develop and disseminate educational documents, materials and scientific presentations targeted towards clinical and analytical applications of cardiac biomarkers including, but not limited to, cardiac troponin (high-sensitivity, contemporary and point-of-care assays), natriuretic peptides (BNP, NT-proBNP assays) and emerging novel biomarkers.  Deliverables include: 
    published manuscripts, biomarker reference tables, webinars, podcasts, and social media.

 IFCC – Task Force on Outcome Studies in Laboratory Medicine (TF-OSLM) (Corresponding Member)

Terms of Reference:

  • Identify existing peer reviewed, high quality publications that demonstrate the value of laboratory medicine in healthcare overall
  • Develop a funded research program for investigators in hospitals located around the world to conduct new retrospective and prospective research with outcomes that assess the value of laboratory medicine in healthcare overall. The taskforce could help centres in setting up studies to properly collect such data (common study protocols and formats) and publish their findings
  • Create a repository/database of publications that is accessible by members of IFCC
  • Working with CPD and the C-PR, the taskforce will develop publications, presentations, webinars and other communications materials to help IFCC members use this data to effectively promote the critical value of laboratory medicine in healthcare to key stakeholders
  • The Taskforce will closely coordinate with other IFCC groups involved in related activities, including CPD, C-VPLM, TF-CM and others, as required

SEMEDLAB representative

The IFCC governing body is the Council that consists of one Representative appointed by each Full Member (voting), Affiliate Member, and Corporate Member. It convenes at the triennial International Congress of Clinical Chemistry and Laboratory Medicine.

IFCC – Education and Management Division – Laboratory Errors and Patient Safety (WG-LEPS) (Member)

Current Projects

  • Improving awareness of laboratory professionals regarding the topic of errors and patient safety
  • Implementing pilot studies to evaluate laboratory errors frequency and types
  • Implementing projects for error reduction through the design of safer procedures and processes
  • Cooperating with other scientific organizations (WHO, AACC, ASCP, etc) for assuring improvements in the field of patient safety
  • Organizing meetings and scientific sessions on the topic of laboratory errors and patient safety
  • Supporting the publications of papers on the topic of laboratory errors and patient safety in scientific journals and monographies

IFCC – Clinical Laboratory Management (C-CLM) (Corresponding member)

Terms of Reference
The C-CLM promotes good management practices in clinical laboratories. The committee’s mandate is to produce monographs and/or guides on basic clinical laboratory management, quality requirements recognized in major quality management guidelines and to offer training modules, seminars, workshops and expertise to laboratory professionals whose purpose is to define organizational structure and carry out crucial activities necessary to achieve quality in routine clinical laboratory services. The committee aims to produce standardized workshop material for basic and advanced management courses. The committee also focuses on addressing the challenges and needs of clinical laboratories in developing countries who have the aim to continually improve towards ensuring patient safety and/or to meet accreditation standards.

IFCC – Committe on Artificial Intelligence in Laboratory Medicine (C-AILM) (Member)

Terms of Reference

  • To evaluate and monitor the latest trends and advancements in research and development in the field defined by the intersection of Laboratory Medicine, Clinical Diagnostics, and Artificial Intelligence (AI)
  • To address the challenges hindering the effective implementation of AI in Laboratory Medicine
  • To promote the discussion and awareness of the necessity and benefits of integrating emerging AI technologies in Laboratory Medicine
  • To foster collaborations and partnership with academic institutes, industry leaders, and other relevant organizations to advance the applications of AI technologies in Laboratory Medicine
  • To contribute to the development of international standards that guide the use of AI in Laboratory Medicine and Clinical Diagnostics.

IFCC – Education and Management Division: Committee on Point of Care Testing (C-POCT) (Consultant)

Terms of reference

  • To promote quality in the use, performance, interpretation and reporting of POCT across the full spectrum of clinical chemistry and laboratory medicine
  • To create a forum for high level discussion on a wide range of POCT related topics
  • To provide international leadership for developing the clinical practice of POCT in Laboratory Medicine

IFCC – Standardization of Fetal Hemoglobin (WG-HbF) (Corresponding Member)

Terms of Reference

  • Promoting the use of an LC-MS/MS method as the accuracy base for standardization of HbF
  • Maintaining sustainability of an international network of reference laboratories

IFCC – C-EBLM (Member)

The aims and objectives of the Committee on Evidence-based Laboratory Medicine are to:

  • Promote the understanding and the methodology of EBLM by educating laboratory professionals
  • Support rational laboratory use by implementation of results from EBLM into daily practice. This can be achieved by methodological  research, international surveys
  • Promote the international dissemination of and collaboration in EBLM

IFCC – Committee on Point of Care Testing (C-POCT) (Member)

Terms of Reference

  • To promote quality in the use, performance, interpretation and reporting of POCT across the full spectrum of clinical chemistry and laboratory medicine
  • To create a forum for high level discussion on a wide range of POCT related topics
  • To provide international leadership for developing the clinical practice of POCT in Laboratory Medicine

IFCC – Committee on Clinical Molecular Biology Curriculum C-CMBC (Member)

Terms of Reference

The objective of the C-CMBC is to develop curriculum and hold training courses in Molecular Biology techniques. In addition, C-CMBC will develop techniques for teaching Clinical Molecular Biology in Laboratory Medicine and courses in teaching Clinical Molecular Biology.

National representative

Division General Laboratory Medicine/Polyvalent Medical Biopathology (Member)


The Section’s main activities include:

  • Developing harmonized curricula for specialist training

  • Evaluating and accrediting CME programs

  • Conducting site visitations for training centers

  • Organizing the European Board Examination in Laboratory Medicine / Medical Biopathology, which grants the title of Fellow of the European Board (F.E.B. LM/MB) — a mark of professional excellence across Europe

Division General Laboratory Medicine/Polyvalent Medical Biopathology (Member)

The Section’s main activities include:

  • Developing harmonized curricula for specialist training

  • Evaluating and accrediting CME programs

  • Conducting site visitations for training centers

  • Organizing the European Board Examination in Laboratory Medicine / Medical Biopathology, which grants the title of Fellow of the European Board (F.E.B. LM/MB) — a mark of professional excellence across Europe

Buscador